[Abstract] Diatoms are an ecologically important group of eukaryotic microalgae with properties that make them attractive for biotechnological applications such as biofuels, foods, cosmetics and pharmaceuticals. Phaeodactylum tricornutum is a model diatom with defined culture conditions, but routine genetic manipulations are hindered by a lack of simple and robust genetic tools. One obstacle to efficient engineering of P. tricornutum is that the current selection methods for P. tricornutum transformants depend on the use of a limited number of antibiotic resistance genes. An alternative and more cost-effective selection method would be to generate auxotrophic strains of P. tricornutum by knocking out key genes involved in amino acid biosynthesis, and using plasmid-based copies of the biosynthetic genes as selective markers. Previous work on gene knockouts in P. tricornutum used biolistic transformation to deliver CRISPR-Cas9 system into P. tricornutum. Biolistic transformation of non-replicating plasmids can cause undesired damage to P. tricornutum due to random integration of the transformed DNA into the genome. Subsequent curing of edited cells to prevent long-term overexpression of Cas9 is very difficult as there is currently no method to excise integrated plasmids.
an oligonucleotide corresponding to the predicted gRNA binding site (underlined sequence in Up to 50 μl 2. Clone gRNAs into the pKSconj diaCas9 and pKSconj diaTevCas9 plasmids using Golden Gate assembly (Table 3) . Place the reaction in a thermocycler and run the protocol as described in plasmid miniprep kit). Send isolated plasmid DNA for Sanger sequencing at the London Regional Genomics Centre using a sequencing primer upstream of the gRNA insertion site to identify a plasmid containing a properly cloned gRNA.
6. Transform the properly cloned gRNA plasmid into Epi300 E. coli containing the pTA-Mob (Strand et al., 2014) plasmid, obtained from Dr. Rahmi Lale, using the heat shock protocol described in
Step 3 with 1 μl of plasmid and 30 μl of E. coli cells.
C. Transfer of plasmid into P. tricornutum via conjugation from E. coli
Note: This protocol was adapted from a published protocol (Karas et al., 2015 3. Add 2 ml of L1 media to the plate, scrape and collect cells into a 1.5 ml Eppendorf tube.
4. Count the cells using a hemocytometer and adjust the concentration to 5 x 10 8 cells ml -1 .
5. Grow 3 ml E. coli cultures containing the diaCas9 or diaTevCas9 plasmids with gRNAs at 37 °C overnight. Dilute 1 ml of overnight culture to 50 ml of LB with 100 μg ml -1 ampicillin and 40 μg ml -1 gentamicin and grow the culture to an OD600 of 0.8-1.0.
6. Centrifuge the culture for 10 min at 3,000 x g in a 50 ml Falcon tube.
7. Discard the supernatant and resuspend the pellet in 500 μl SOC media. 1. After 14 days, randomly select ten P. tricornutum exconjugants and streak them onto an L1 + Zeocin TM plate and grow for 7 days.
2. Scrape 50% of the cells from one streak and place it into 3 ml of L1 media with 50 μg ml 3. Use the lysed P. tricornutum exconjugant cells as the template for PCR amplification of the gRNA target site using AmpliTaq DNA polymerase. Design the PCR so the product will be ~500 bp using primers located ~250 bp upstream and downstream of the gRNA target site. Analyze the PCR products on a 1% agarose gel to confirm the size and presence of the PCR product.
4. Denature the PCR product at 95 °C for 5 min and slowly cool to 50 °C and then freeze the sample at -20 °C for 2 min to generate heteroduplexes of edited and unedited target sites.
5. Use the PCR product as the substrate for a T7EI assay (Table 5 ). Incubate the reaction at 37 °C for 15 min and analyze the digested product on a 1% agarose gel. PCR products from exconjugant that yield two bands on the agarose gel (500 bp and 250 bp) contains editing at the target site by Cas9 or TevCas9. An example of the T7EI assay gel is shown in Figure 4 . E. Phenotypic screening of urease knockouts (see Figure 5 for an example of the phenotypic screen) 2. PCR amplify the target site, as in Steps D2-D3, from sub-clones identified as urease knockouts and send the PCR product for Sanger sequencing.
F. Curing of the pKSconj diaCas9 and diaTevCas9 plasmids from urease knockout sub-clones 
